导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -19.92% | 4418/4773 |
| 近一周 | -0.95% | 812/5458 |
| 近一月 | -1.20% | 1097/5421 |
| 近一季 | -8.25% | 3728/5205 |
| 近半年 | -26.70% | 4822/4920 |
| 近一年 | -15.59% | 3756/4361 |
| 近两年 | 24.85% | 2542/2954 |
| 近三年 | -3.14% | 1980/2253 |
| 成立以来 | 74.81% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-1.58% 2374/4961 |
-18.77% 4818/5312 |
- - |
- - |
| 2025 | 25.48% 1708/4813 |
5.79% 731/3635 |
-2.78% 3377/4076 |
15.47% 2800/4524 |
5.65% 417/4813 |
| 2024 | 2.77% 1957/3463 |
- 1057/2808 |
-7.63% 2105/3014 |
12.27% 2383/3129 |
-0.90% 1541/3463 |
| 2023 | -4.86% 699/2656 |
2.60% 1330/2280 |
-5.24% 1405/2385 |
2.43% 235/2515 |
-4.47% 1046/2655 |
| 2022 | -19.44% 850/2207 |
-7.87% 257/1919 |
1.57% 1454/2016 |
-14.50% 1107/2113 |
0.69% 1466/2208 |
| 2021 | 40.93% 27/1822 |
16.05% 3/1255 |
9.66% 538/1330 |
20.05% 46/1466 |
-7.75% 1573/1822 |
| 2020 | - - |
- - |
8.48% 822/1067 |
5.07% 930/1164 |
7.71% 698/1184 |
| 2019 | - - |
- - |
- - |
- - |
- - |
| 2018 | - - |
- - |
- - |
- - |
- - |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 万家中证港股通创新药ETF | 1.5896 | 28.31% |
| 港股医疗ETF | 1.4282 | 28.15% |
| 天弘恒生沪深港创新药精选50ETF | 0.8437 | 27.35% |
| 华富中证港股通创新药指数型发起式A | 1.1464 | 27.24% |
| 嘉实中证港股通创新药指数发起式C | 0.8441 | 26.80% |
| 中欧中证港股通创新药指数发起A | 1.5868 | 26.75% |
| 中欧中证港股通创新药指数发起C | 1.4370 | 26.67% |
| 永赢中证港股通医疗主题ETF发起联接A | 0.8762 | 26.58% |
| 华夏中证港股通医疗主题ETF发起式联接A | 0.8585 | 26.45% |
| 华夏中证港股通医疗主题ETF发起式联接C | 0.8568 | 26.39% |
| 国泰中证钢铁ETF联接A VS. 长安沪深300非周期A(740101) |